{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:15:17Z","timestamp":1792185317822,"version":"4.4.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/15\/2024-01-00616"],"award-info":[{"award-number":["EMDR\/SG\/15\/2024-01-00616"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/15\/2024-01-00616"],"award-info":[{"award-number":["EMDR\/SG\/15\/2024-01-00616"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/15\/2024-01-00616"],"award-info":[{"award-number":["EMDR\/SG\/15\/2024-01-00616"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04520-x","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T14:08:08Z","timestamp":1775138888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Advances in methotrexate nano-formulations to enhance therapeutic efficacy against drug-resistant breast cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Satyajit","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barsha","family":"Dassarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Ashif","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragati","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devlina Das","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzang","family":"Chosdol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"13","key":"4520_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, Crews JR, Denduluri N, Hwang ES, Khan SA, Loibl S, Morris EA, Perez A. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021;39(13):1485\u2013505.","journal-title":"J Clin Oncol"},{"issue":"20","key":"4520_CR2","doi-asserted-by":"publisher","first-page":"2001032","DOI":"10.1002\/adhm.202001032","volume":"9","author":"Z Chen","year":"2020","unstructured":"Chen Z, Cai Z, Zhu C, Song X, Qin Y, Zhu M, Zhang T, Cui W, Tang H, Zheng H. Injectable and self-healing hydrogel with anti\u2010bacterial and anti\u2010inflammatory properties for acute bacterial rhinosinusitis with micro invasive treatment. Adv Healthc Mater. 2020;9(20):2001032.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"4520_CR3","doi-asserted-by":"publisher","first-page":"e0140842","DOI":"10.1371\/journal.pone.0140842","volume":"10","author":"GS Liem","year":"2015","unstructured":"Liem GS, Mo FKF, Pang E, Suen JJS, Tang NLS, Lee KM, Yip CHW, Tam WH, Ng R, Koh J. Chemotherapy-related amenorrhea and menopause in young Chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles. PLoS ONE. 2015;10(10):e0140842.","journal-title":"PLoS ONE"},{"issue":"2","key":"4520_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000265166","volume":"115","author":"K Chatterjee","year":"2010","unstructured":"Chatterjee K, Zhang J, Honbo N, Karliner JS. Doxorubicin cardiomyopathy. Cardiology. 2010;115(2):155\u201362.","journal-title":"Cardiology"},{"issue":"16","key":"4520_CR5","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/s41388-021-01720-w","volume":"40","author":"SA Hutchinson","year":"2021","unstructured":"Hutchinson SA, Websdale A, Cioccoloni G, R\u00f8berg-Larsen H, Lianto P, Kim B, Rose A, Soteriou C, Pramanik A, Wastall LM. Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene. 2021;40(16):2872\u201383.","journal-title":"Oncogene"},{"key":"4520_CR6","doi-asserted-by":"crossref","unstructured":"Kuo MT. Roles of multidrug resistance genes in breast cancer chemoresistance. In: Breast cancer chemosensitivity. Berlin: Springer; 2007. pp. 23\u201330.","DOI":"10.1007\/978-0-387-74039-3_2"},{"key":"4520_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fonc.2020.01152","volume":"10","author":"S Romero-Garcia","year":"2020","unstructured":"Romero-Garcia S, Prado-Garcia H, Carlos-Reyes A. Role of DNA methylation in the resistance to therapy in solid tumors. Front Oncol. 2020;10:1152.","journal-title":"Front Oncol"},{"key":"4520_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-5-30","volume":"5","author":"C-H Choi","year":"2005","unstructured":"Choi C-H. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int. 2005;5:1\u201313.","journal-title":"Cancer Cell Int"},{"issue":"8","key":"4520_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1349-7006.2005.00081.x","volume":"96","author":"Y Sugimoto","year":"2005","unstructured":"Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J. Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics\/pharmacodynamics. Cancer Sci. 2005;96(8):457\u201365.","journal-title":"Cancer Sci"},{"issue":"6","key":"4520_CR10","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/annonc\/mdg260","volume":"14","author":"M Martin","year":"2003","unstructured":"Martin M, Villar A, Sole-Calvo A, Gonzalez R, Massuti B, Lizon J, Camps C, Carrato A, Casado A, Candel MT. Doxorubicin in combination with fluorouracil and cyclophosphamide (iv FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (iv CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group. Ann Oncol. 2003;14(6):833\u201342.","journal-title":"Ann Oncol"},{"key":"4520_CR11","doi-asserted-by":"publisher","first-page":"115971","DOI":"10.1016\/j.ejmech.2023.115971","volume":"264","author":"JI Brown","year":"2024","unstructured":"Brown JI, Persaud R, Iliev P, Karmacharya U, Attarha S, Sahile H, Olsen JE, Hanke D, Idowu T, Frank DA. Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens. Eur J Med Chem. 2024;264:115971.","journal-title":"Eur J Med Chem"},{"issue":"8","key":"4520_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/jpm11080771","volume":"11","author":"J Wu","year":"2021","unstructured":"Wu J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J Personal. Med. 2021;11(8):771.","journal-title":"J personalized Med"},{"issue":"1","key":"4520_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/1061186X.2013.832768","volume":"22","author":"A Pramanik","year":"2014","unstructured":"Pramanik A, Laha D, Pramanik P, Karmakar P. A novel drug copper acetylacetonate loaded in folic acid-tagged chitosan nanoparticle for efficient cancer cell targeting. J Drug Target. 2014;22(1):23\u201333.","journal-title":"J Drug Target"},{"key":"4520_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.msec.2016.05.014","volume":"68","author":"A Pramanik","year":"2016","unstructured":"Pramanik A, Laha D, Dash SK, Chattopadhyay S, Roy S, Das DK, Pramanik P, Karmakar P. An in-vivo study for targeted delivery of copper-organic complex to breast cancer using chitosan polymer nanoparticles. Mater Sci Eng C. 2016;68:327\u201337.","journal-title":"Mater Sci Engineering: C"},{"issue":"4","key":"4520_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13205-021-02718-7","volume":"11","author":"R Chaudhari","year":"2021","unstructured":"Chaudhari R, Patel P, Meghani N, Nasra S, Kumar A. Fabrication of methotrexate-loaded gold nanoconjugates and its enhanced anticancer activity in breast cancer. 3 Biotech. 2021;11(4):175.","journal-title":"3 Biotech"},{"issue":"1","key":"4520_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/pharmaceutics15010227","volume":"15","author":"R Rani","year":"2023","unstructured":"Rani R, Malik P, Dhania S, Mukherjee TK. Recent advances in mesoporous silica nanoparticle-mediated drug delivery for breast cancer treatment. Pharmaceutics. 2023;15(1):227.","journal-title":"Pharmaceutics"},{"key":"4520_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jddst.2015.10.004","volume":"30","author":"M Ekinci","year":"2015","unstructured":"Ekinci M, Ilem-Ozdemir D, Gundogdu E, Asikoglu M. Methotrexate loaded chitosan nanoparticles: preparation, radiolabeling and in vitro evaluation for breast cancer diagnosis. J Drug Deliv Sci Technol. 2015;30:107\u201313.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4520_CR18","doi-asserted-by":"publisher","first-page":"101769","DOI":"10.1016\/j.jddst.2020.101769","volume":"58","author":"SA Torres-Perez","year":"2020","unstructured":"Torres-Perez SA, Ramos-God\u00ednez MdelP, Ramon-Gallegos E. Glycosylated one-step PAMAM dendrimers loaded with methotrexate for target therapy in breast cancer cells MDA-MB-231. J Drug Deliv Sci Technol. 2020;58:101769.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4520_CR19","doi-asserted-by":"publisher","first-page":"146941","DOI":"10.1016\/j.gene.2022.146941","volume":"851","author":"Z Taran","year":"2023","unstructured":"Taran Z, Digehsaraei SY, Salouti M, Amini B, Mahmazi S, Kalantari M. Methotrexate loaded in alginate beads for controlled drug release against breast cancer. Gene. 2023;851:146941.","journal-title":"Gene"},{"issue":"3","key":"4520_CR20","doi-asserted-by":"publisher","first-page":"e70040","DOI":"10.1002\/tqem.70040","volume":"34","author":"SS Shabnum","year":"2025","unstructured":"Shabnum SS, Siranjeevi R, Raj CK, Nivetha P, Benazir K. A comprehensive review on recent progress in carbon nanotubes for biomedical application. Environ Qual Manag. 2025;34(3):e70040.","journal-title":"Environ Qual Manage"},{"issue":"4","key":"4520_CR21","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.3390\/ijms16048070","volume":"16","author":"J Estelrich","year":"2015","unstructured":"Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16(4):8070\u2013101.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4520_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ijpharm.2017.09.061","volume":"533","author":"N Tahir","year":"2017","unstructured":"Tahir N, Madni A, Balasubramanian V, Rehman M, Correia A, Kashif PM, M\u00e4kil\u00e4 E, Salonen J, Santos HA. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications. Int J Pharm. 2017;533(1):156\u201368.","journal-title":"Int J Pharm"},{"key":"4520_CR23","doi-asserted-by":"publisher","first-page":"118480","DOI":"10.1016\/j.ijpharm.2019.118480","volume":"567","author":"A Jain","year":"2019","unstructured":"Jain A, Jain SK. Methotrexate-loaded hybrid nanoparticles for improved pharmacokinetics and enhanced anticancer activity in breast cancer therapy. Int J Pharm. 2019;567:118480. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118480.","journal-title":"Int J Pharm"},{"key":"4520_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.colsurfb.2016.05.051","volume":"146","author":"NK Garg","year":"2016","unstructured":"Garg NK, Singh B, Jain A, Nirbhavane P, Sharma R, Tyagi RK, Kushwah V, Jain S, Katare OP. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B. 2016;146:114\u201326.","journal-title":"Colloids Surf B"},{"issue":"2","key":"4520_CR25","doi-asserted-by":"publisher","first-page":"7946","DOI":"10.37285\/ijpsn.2025.18.2.6","volume":"18","author":"S Upadhyay","year":"2025","unstructured":"Upadhyay S, Soni G. Design, Optimization and Characterization of Methotrexate Solid Lipid Nanoparticles for the Effective Management of Rheumatoid Arthritis. Scopus Index [Internet]. 2025;18(2):7946\u201357. https:\/\/doi.org\/10.37285\/ijpsn.2025.18.2.6.","journal-title":"Scopus Index [Internet]"},{"issue":"2","key":"4520_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/pharmaceutics11020065","volume":"11","author":"E Muntoni","year":"2019","unstructured":"Muntoni E, Martina K, Marini E, Giorgis M, Lazzarato L, Salaroglio IC, Riganti C, Lanotte M, Battaglia L. Methotrexate-loaded solid lipid nanoparticles: Protein functionalization to improve brain biodistribution. Pharmaceutics. 2019;11(2):65.","journal-title":"Pharmaceutics"},{"issue":"6","key":"4520_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jsps.2023.04.007","volume":"31","author":"D Maiti","year":"2023","unstructured":"Maiti D, Inamdar MN, Almuqbil M, Suresh S, Asdaq SMB, Alshehri S, Al Arfaj SA, Alamri AM, Aldohyan MM, Alqahtani MT. Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity. Saudi Pharm J. 2023;31(6):834\u201344.","journal-title":"Saudi Pharm J"},{"key":"4520_CR28","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.ijbiomac.2018.08.110","volume":"120","author":"EMM Ali","year":"2018","unstructured":"Ali EMM, Hussein MA, Abdel-Magied AF. Methotrexate loaded chitosan-coated magnetite nanoparticles as a targeted drug delivery system for breast cancer therapy. Int J Biol Macromol. 2018;120:1170\u201380. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.08.110.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4520_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s11671-020-3295-1","volume":"15","author":"R Agabeigi","year":"2020","unstructured":"Agabeigi R, Rasta SH, Rahmati-Yamchi M, Salehi R, Alizadeh E. Novel chemo-photothermal therapy in breast cancer using methotrexate-loaded folic acid conjugated Au@ SiO2 nanoparticles. Nanoscale Res Lett. 2020;15(1):62.","journal-title":"Nanoscale Res Lett"},{"key":"4520_CR30","doi-asserted-by":"publisher","first-page":"9050","DOI":"10.1038\/s41598-021-88561-w","volume":"11","author":"RG Chaudhari","year":"2021","unstructured":"Chaudhari RG, Taware SD, Patil SB. Fabrication of methotrexate-gold nanoparticle conjugates and evaluation of anticancer activity in breast cancer cells. Sci Rep. 2021;11:9050. https:\/\/doi.org\/10.1038\/s41598-021-88561-w.","journal-title":"Sci Rep"},{"issue":"1","key":"4520_CR31","doi-asserted-by":"publisher","first-page":"21899","DOI":"10.1038\/s41598-023-49464-9","volume":"13","author":"J Raut","year":"2023","unstructured":"Raut J, Sarkar O, Das T, Mandal SM, Chattopadhyay A, Sahoo P. Efficient delivery of methotrexate to MDA-MB-231 breast cancer cells by a pH-responsive ZnO nanocarrier. Sci Rep. 2023;13(1):21899.","journal-title":"Sci Rep"},{"key":"4520_CR32","doi-asserted-by":"publisher","first-page":"126293","DOI":"10.1016\/j.ijpharm.2025.126293","volume":"23","author":"A Aliabadi","year":"2025","unstructured":"Aliabadi A, Ramezani M, Sheikhi-Mohammareh S, Abnous K, Taghdisi SM, Alibolandi M. Synthesis of glutathione-responsive, amphiphilic methotrexate-based prodrug nanoparticles: In vitro and in vivo assessment against metastatic breast cancer. Int J Pharm. 2025;686:126293. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.126293.","journal-title":"Int J Pharm"},{"issue":"1","key":"4520_CR33","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1080\/10717544.2021.1985884","volume":"28","author":"MM Elfadele","year":"2021","unstructured":"Elfadele MM. pH-responsive methotrexate-loaded bilosomes enhance apoptosis and anticancer activity in breast cancer cells. Drug Deliv. 2021;28(1):1974\u201386. https:\/\/doi.org\/10.1080\/10717544.2021.1985884.","journal-title":"Drug Delivery"},{"issue":"2","key":"4520_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jhep.2017.03.005","volume":"67","author":"A Huang","year":"2017","unstructured":"Huang A, Zhao X, Yang X-R, Li F-Q, Zhou X-L, Wu K, Zhang X, Sun Q-M, Cao Y, Zhu H-M. Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma. J Hepatol. 2017;67(2):293\u2013301.","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"4520_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijpharm.2015.07.036","volume":"493","author":"Q Luo","year":"2015","unstructured":"Luo Q, Lin T, Zhang CY, Zhu T, Wang L, Ji Z, Jia B, Ge T, Peng D, Chen W. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: preparation, cytotoxicity and intracellular uptake. Int J Pharm. 2015;493(1\u20132):30\u20139.","journal-title":"Int J Pharm"},{"issue":"13","key":"4520_CR36","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-07-4592","volume":"14","author":"ER Gardner","year":"2008","unstructured":"Gardner ER, Dahut WL, Scripture CD, Jones J, Aragon-Ching JB, Desai N, Hawkins MJ, Sparreboom A, Figg WD. Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel. Clin Cancer Res. 2008;14(13):4200\u20135.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4520_CR37","first-page":"581363","volume":"2012","author":"GP Stathopoulos","year":"2012","unstructured":"Stathopoulos GP, Boulikas T. Lipoplatin formulation review article. J Drug Deliv. 2012;2012(1):581363.","journal-title":"J drug delivery"},{"key":"4520_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biomaterials.2016.06.023","volume":"103","author":"M Guan","year":"2016","unstructured":"Guan M, Ge J, Wu J, Zhang G, Chen D, Zhang W, Zhang Y, Zou T, Zhen M, Wang C. Fullerene\/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy. Biomaterials. 2016;103:75\u201385.","journal-title":"Biomaterials"},{"key":"4520_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00280-014-2671-x","volume":"75","author":"TC Chang","year":"2015","unstructured":"Chang TC, Shiah HS, Yang CH, Yeh KH, Cheng AL, Shen BN, Wang YW, Yeh CG, Chiang NJ, Chang JY. Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients. Cancer Chemother Pharmacol. 2015;75:579\u201386.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4520_CR40","doi-asserted-by":"publisher","first-page":"20220615","DOI":"10.1515\/biol-2022-0615","volume":"18","author":"D Wang","year":"2023","unstructured":"Wang D, Zhao P, Lu T, Ren J, Zhu L, Han X, Zhang G, Dong X, Ma H, Yu M. ctDNA as a prognostic biomarker in resectable CLM: systematic review and meta-analysis. Open Life Sci. 2023;18(1):20220615.","journal-title":"Open Life Sci"},{"issue":"S36","key":"4520_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jcb.1142","volume":"81","author":"RI Yarden","year":"2001","unstructured":"Yarden RI, Wilson MA, Chrysogelos SA. Estrogen suppression of EGFR expression in breast cancer cells: a possible mechanism to modulate growth. J Cell Biochem. 2001;81(S36):232\u201346.","journal-title":"J Cell Biochem"},{"issue":"7","key":"4520_CR42","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117\u201334.","journal-title":"Cell"},{"key":"4520_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0959-8049(01)00231-3","volume":"37","author":"RI Nicholson","year":"2001","unstructured":"Nicholson RI, Gee JMW, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37:9\u201315.","journal-title":"Eur J Cancer"},{"issue":"9210","key":"4520_CR44","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","volume":"355","author":"J Crown","year":"2000","unstructured":"Crown J, O\u2019Leary M. The taxanes: an update. Lancet. 2000;355(9210):1176\u20138.","journal-title":"Lancet"},{"issue":"4","key":"4520_CR45","first-page":"1009","volume":"29","author":"T Shimada","year":"2009","unstructured":"Shimada T, Ueda M, Jinno H, Chiba N, Wada M, Watanabe J, Ishihara K, Kitagawa Y. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Anticancer Res. 2009;29(4):1009\u201314.","journal-title":"Anticancer Res"},{"issue":"7","key":"4520_CR46","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/ijc.23244","volume":"122","author":"L McLean","year":"2008","unstructured":"McLean L, Soto U, Agama K, Francis J, Jimenez R, Pommier Y, Sowers L, Brantley E. Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells. Int J Cancer. 2008;122(7):1665\u201374.","journal-title":"Int J Cancer"},{"key":"4520_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-344","volume":"14","author":"AM Brinkman","year":"2014","unstructured":"Brinkman AM, Wu J, Ersland K, Xu W. Estrogen receptor \u03b1 and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells. BMC Cancer. 2014;14:1\u201316.","journal-title":"BMC Cancer"},{"issue":"2","key":"4520_CR48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/biomedicines9020114","volume":"9","author":"S Jahan","year":"2021","unstructured":"Jahan S, Karim ME, Chowdhury EH. Nanoparticles targeting receptors on breast cancer for efficient delivery of chemotherapeutics. Biomedicines. 2021;9(2):114.","journal-title":"Biomedicines"},{"key":"4520_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.biomaterials.2016.05.041","volume":"101","author":"AM Brinkman","year":"2016","unstructured":"Brinkman AM, Chen G, Wang Y, Hedman CJ, Sherer NM, Havighurst TC, Gong S, Xu W. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Biomaterials. 2016;101:20\u201331.","journal-title":"Biomaterials"},{"key":"4520_CR50","doi-asserted-by":"publisher","first-page":"101682","DOI":"10.1016\/j.jddst.2020.101682","volume":"57","author":"BD Kurmi","year":"2020","unstructured":"Kurmi BD, Patel P, Paliwal R, Paliwal SR. Molecular approaches for targeted drug delivery towards cancer: a concise review with respect to nanotechnology. J Drug Deliv Sci Technol. 2020;57:101682.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"4520_CR51","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","volume":"56","author":"S Sabharanjak","year":"2004","unstructured":"Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004;56(8):1099\u2013109.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4\u20136","key":"4520_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","volume":"17","author":"YG Assaraf","year":"2014","unstructured":"Assaraf YG, Leamon CP, Reddy JA. The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resist Updates. 2014;17(4\u20136):89\u201395.","journal-title":"Drug Resist Updates"},{"issue":"14","key":"4520_CR53","doi-asserted-by":"publisher","first-page":"17442","DOI":"10.18632\/oncotarget.7856","volume":"7","author":"LSF Boogerd","year":"2016","unstructured":"Boogerd LSF, Boonstra MC, Beck A-J, Charehbili A, Hoogstins CES, Prevoo HAJM, Singhal S, Low PS, van de Velde CJH, Vahrmeijer AL. Concordance of folate receptor-\u03b1 expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients. Oncotarget. 2016;7(14):17442.","journal-title":"Oncotarget"},{"issue":"8","key":"4520_CR54","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","volume":"56","author":"H Elnakat","year":"2004","unstructured":"Elnakat H. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Deliv Rev. 2004;56(8):1067\u201384.","journal-title":"Adv Drug Deliv Rev"},{"key":"4520_CR55","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.colsurfb.2018.07.013","volume":"170","author":"ZC Soe","year":"2018","unstructured":"Soe ZC, Thapa RK, Ou W, Gautam M, Nguyen HT, Jin SG, Ku SK, Oh KT, Choi H-G, Yong CS. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy. Colloids Surf B. 2018;170:718\u201328.","journal-title":"Colloids Surf B"},{"issue":"4","key":"4520_CR56","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015;115(4):1990\u20132042.","journal-title":"Chem Rev"},{"key":"4520_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ejpb.2018.11.009","volume":"134","author":"L Boge","year":"2019","unstructured":"Boge L, Hallstensson K, Ringstad L, Johansson J, Andersson T, Davoudi M, Larsson PT, Mahlapuu M, H\u00e5kansson J, Andersson M. Cubosomes for topical delivery of the antimicrobial peptide LL-37. Eur J Pharm Biopharm. 2019;134:60\u20137.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2\u20133","key":"4520_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0925-4439(02)00088-1","volume":"1587","author":"IH Gilbert","year":"2002","unstructured":"Gilbert IH. Inhibitors of dihydrofolate reductase in leishmania and trypanosomes. Biochim Biophys Acta BBA Mol Basis Dis. 2002;1587(2\u20133):249\u201357.","journal-title":"Basis Disease"},{"issue":"1","key":"4520_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metabol. 2017;25(1):27\u201342.","journal-title":"Cell Metabol"},{"issue":"3","key":"4520_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Jt Bone Spine. 2019;86(3):301\u20137.","journal-title":"Joint bone spine"},{"key":"4520_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-018-0592-5","volume":"8","author":"IHR Abbasi","year":"2018","unstructured":"Abbasi IHR, Abbasi F, Wang L, Abd El Hack ME, Swelum AA, Hao R, Yao J, Cao Y. Folate promotes S-adenosyl methionine reactions and the microbial methylation cycle and boosts ruminants production and reproduction. Amb Express. 2018;8:1\u201310.","journal-title":"Amb Express"},{"issue":"3","key":"4520_CR62","doi-asserted-by":"publisher","first-page":"e91805","DOI":"10.1371\/journal.pone.0091805","volume":"9","author":"A Avraham","year":"2014","unstructured":"Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, Pappo I, Halperin R, Vaknin Z, Sella A. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer. PLoS ONE. 2014;9(3):e91805.","journal-title":"PLoS ONE"},{"issue":"5","key":"4520_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2021.5278","volume":"59","author":"MT Vietri","year":"2021","unstructured":"Vietri MT, D\u2019Elia G, Benincasa G, Ferraro G, Caliendo G, Nicoletti GF, Napoli C. DNA methylation and breast cancer: a way forward. Int J Oncol. 2021;59(5):1\u201312.","journal-title":"Int J Oncol"},{"issue":"7","key":"4520_CR64","doi-asserted-by":"publisher","first-page":"e1001043","DOI":"10.1371\/journal.pgen.1001043","volume":"6","author":"BC Christensen","year":"2010","unstructured":"Christensen BC, Kelsey KT, Zheng S, Houseman EA, Marsit CJ, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Kushi LH. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010;6(7):e1001043.","journal-title":"PLoS Genet"},{"key":"4520_CR65","doi-asserted-by":"publisher","first-page":"113511","DOI":"10.1016\/j.biopha.2022.113511","volume":"153","author":"L Liu","year":"2022","unstructured":"Liu L, An X, Schaefer M, Yan B, de la Torre C, Hillmer S, Gladkich J, Herr I. Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. Biomed Pharmacother. 2022;153:113511.","journal-title":"Biomed Pharmacother"},{"key":"4520_CR66","doi-asserted-by":"publisher","first-page":"1331687","DOI":"10.3389\/fphar.2023.1331687","volume":"14","author":"Y Chen","year":"2024","unstructured":"Chen Y, Fang H, Sun H, Wu X, Xu Y, Zhou B-BS, Li H. Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells. Front Pharmacol. 2024;14:1331687.","journal-title":"Front Pharmacol"},{"key":"4520_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2187","volume":"9","author":"AE Koch","year":"2007","unstructured":"Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res therapy. 2007;9:1\u20139.","journal-title":"Arthritis Res therapy"},{"issue":"3","key":"4520_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/10739689509146768","volume":"2","author":"JR Levick","year":"1995","unstructured":"Levick JR. Microvascular architecture and exchange in synovial joints. Microcirculation. 1995;2(3):217\u201333.","journal-title":"Microcirculation"},{"issue":"3","key":"4520_CR69","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i3.20","volume":"18","author":"C Halin","year":"2001","unstructured":"Halin C, Neri D. Antibody-based targeting of angiogenesis. Crit Rev Ther Drug Carrier Syst. 2001;18(3):299\u2013339.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"4","key":"4520_CR70","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00001813-199904000-00009","volume":"10","author":"G Stehle","year":"1999","unstructured":"Stehle G, Wunder A, Schrenk HH, Hartung G, Heene DL, Sinn H. Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats. Anticancer Drugs. 1999;10(4):405\u201312.","journal-title":"Anticancer Drugs"},{"key":"4520_CR71","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10549-008-9943-2","volume":"113","author":"GG Kimmick","year":"2009","unstructured":"Kimmick GG, Cirrincione C, Duggan DB, Bhalla K, Robert N, Berry D, Norton L, Lemke S, Henderson IC, Hudis C. Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944). Breast Cancer Res Treat. 2009;113:479\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"4520_CR72","doi-asserted-by":"crossref","unstructured":"Sezer AD. Application of nanotechnology in drug delivery. BoD\u2013Books on Demand; 2014.","DOI":"10.5772\/57028"},{"issue":"9","key":"4520_CR73","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s13346-022-01157-y","volume":"12","author":"AKO \u00c5slund","year":"2022","unstructured":"\u00c5slund AKO, Vandebriel RJ, Caputo F, De Jong WH, Delmaar C, Hyldbakk A, Rustique E, Schmid R, Snipstad S, Texier I. A comparative biodistribution study of polymeric and lipid-based nanoparticles. Drug Deliv Transl Res. 2022;12(9):2114\u201331.","journal-title":"Drug Delivery Translational Res"},{"issue":"13","key":"4520_CR74","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.3390\/ijms20133312","volume":"20","author":"J-H Jang","year":"2019","unstructured":"Jang J-H, Jeong S-H, Lee Y-B. Preparation and in vitro\/in vivo characterization of polymeric nanoparticles containing methotrexate to improve lymphatic delivery. Int J Mol Sci. 2019;20(13):3312.","journal-title":"Int J Mol Sci"},{"key":"4520_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s13346-013-0129-z","volume":"3","author":"J Shen","year":"2013","unstructured":"Shen J, Burgess DJ. vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res. 2013;3:409\u201315.","journal-title":"Drug delivery translational Res"},{"key":"4520_CR76","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.msec.2013.09.004","volume":"34","author":"P Murawala","year":"2014","unstructured":"Murawala P, Tirmale A, Shiras A, Prasad BLV. In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells. Mater Sci Eng C. 2014;34:158\u201367.","journal-title":"Mater Sci Engineering: C"},{"issue":"1","key":"4520_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/21691401.2022.2030746","volume":"50","author":"Z Shakeran","year":"2022","unstructured":"Shakeran Z, Varshosaz J, Keyhanfar M, Mohammad-Beigi H, Rahimi K, Sutherland DS. Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells. Artif Cells Nanomed Biotechnol. 2022;50(1):29\u201339.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"4520_CR78","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3109\/21691401.2014.975235","volume":"44","author":"N Alidadiyani","year":"2016","unstructured":"Alidadiyani N, Salehi R, Ghaderi S, Samadi N, Davaran S. Synergistic antiproliferative effects of methotrexate-loaded smart silica nanocomposites in MDA-MB-231 breast cancer cells. Artif Cells Nanomed Biotechnol. 2016;44(2):603\u20139.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"4520_CR79","doi-asserted-by":"publisher","first-page":"111526","DOI":"10.1016\/j.msec.2020.111526","volume":"118","author":"Z Shakeran","year":"2021","unstructured":"Shakeran Z, Keyhanfar M, Varshosaz J, Sutherland DS. Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment. Mater Sci Eng C. 2021;118:111526.","journal-title":"Mater Sci Engineering: C"},{"issue":"6","key":"4520_CR80","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1021\/acs.molpharmaceut.6b01148","volume":"14","author":"NK Garg","year":"2017","unstructured":"Garg NK, Tyagi RK, Sharma G, Jain A, Singh B, Jain S, Katare OP. Functionalized lipid\u2013polymer hybrid nanoparticles mediated codelivery of methotrexate and aceclofenac: a synergistic effect in breast cancer with improved pharmacokinetics attributes. Mol Pharm. 2017;14(6):1883\u201397.","journal-title":"Mol Pharm"},{"issue":"77","key":"4520_CR81","doi-asserted-by":"publisher","first-page":"62989","DOI":"10.1039\/C5RA12459J","volume":"5","author":"NK Garg","year":"2015","unstructured":"Garg NK, Singh B, Sharma G, Kushwah V, Tyagi RK, Jain S, Katare OP. Development and characterization of single step self-assembled lipid polymer hybrid nanoparticles for effective delivery of methotrexate. RSC Adv. 2015;5(77):62989\u201399.","journal-title":"RSC Adv"},{"issue":"2","key":"4520_CR82","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/ph15020149","volume":"15","author":"N Al-Nemrawi","year":"2022","unstructured":"Al-Nemrawi N, Hameedat F, Al-Husein B, Nimrawi S. Photolytic controlled release formulation of methotrexate loaded in chitosan\/TiO2 nanoparticles for breast cancer. Pharmaceuticals. 2022;15(2):149.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"4520_CR83","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/03639045.2017.1417422","volume":"44","author":"H Nosrati","year":"2018","unstructured":"Nosrati H, Salehiabar M, Davaran S, Danafar H, Manjili HK. Methotrexate-conjugated L-lysine coated iron oxide magnetic nanoparticles for inhibition of MCF-7 breast cancer cells. Drug Dev Ind Pharm. 2018;44(6):886\u201394.","journal-title":"Drug Dev Ind Pharm"},{"issue":"11","key":"4520_CR84","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/jbm.a.36755","volume":"107","author":"E Attari","year":"2019","unstructured":"Attari E, Nosrati H, Danafar H, Kheiri H, Manjili. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier. J Biomed Mater Res Part A. 2019;107(11):2492\u2013500.","journal-title":"J Biomedical Mater Res Part A"},{"key":"4520_CR85","doi-asserted-by":"publisher","first-page":"062005","DOI":"10.1088\/1748-605X\/ad02d4","volume":"18","author":"D Bhattacharya","year":"2023","unstructured":"Bhattacharya D, Mukhopadhyay M, Shivam K, Tripathy S, Patra R, Pramanik A. Recent developments in photodynamic therapy and its application against multidrug resistant cancers. Biomed Mater. 2023;18:062005.","journal-title":"Biomed Mater"},{"issue":"Suppl1","key":"4520_CR86","doi-asserted-by":"publisher","first-page":"e124458","DOI":"10.22037\/ijpr.2020.14484.12423","volume":"18","author":"A Karimi","year":"2019","unstructured":"Karimi A, Erfan M, Mortazavi SA, Ghorbani-Bidkorbeh F, Landi B, Kobarfard F, Shirazi FH. The photothermal effect of targeted methotrexate-functionalized multi-walled carbon nanotubes on MCF7 cells. Iran J Pharm Res. 2019;18(Suppl1):e124458. https:\/\/doi.org\/10.22037\/ijpr.2020.14484.12423.","journal-title":"Iran J Pharm Res"},{"issue":"9","key":"4520_CR87","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1039\/B923560D","volume":"46","author":"C Samor\u00ec","year":"2010","unstructured":"Samor\u00ec C, Ali-Boucetta H, Sainz R, Guo C, Toma FM, Fabbro C, Da Ros T, Prato M, Kostarelos K, Bianco A. Enhanced anticancer activity of multi-walled carbon nanotube\u2013methotrexate conjugates using cleavable linkers. Chem Commun. 2010;46(9):1494\u20136.","journal-title":"Chem Commun"},{"issue":"20","key":"4520_CR88","doi-asserted-by":"publisher","first-page":"10952","DOI":"10.3390\/ijms222010952","volume":"22","author":"M Kus-Li\u015bkiewicz","year":"2021","unstructured":"Kus-Li\u015bkiewicz M, Fickers P, Ben Tahar I. Biocompatibility and cytotoxicity of gold nanoparticles: recent advances in methodologies and regulations. Int J Mol Sci. 2021;22(20):10952.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4520_CR89","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/molecules22091445","volume":"22","author":"F-Y Kong","year":"2017","unstructured":"Kong F-Y, Zhang J-W, Li R-F, Wang Z-X, Wang W-J, Wang W. Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules. 2017;22(9):1445.","journal-title":"Molecules"},{"key":"4520_CR90","doi-asserted-by":"publisher","first-page":"100984","DOI":"10.1016\/j.nexres.2025.100984","volume":"2","author":"T Tyagi","year":"2025","unstructured":"Tyagi T, Solanki R, Patel S, Maity P. Synthesis of methotrexate-conjugated BSA-stabilized gold nanoclusters for improved anticancer efficacy in lung and breast cancer cells. Next Res. 2025;2:100984. https:\/\/doi.org\/10.1016\/j.nexres.2025.100984.","journal-title":"Next Res"},{"key":"4520_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11671-020-3295-1","volume":"15","author":"R Agabeigi","year":"2020","unstructured":"Agabeigi R, Rasta SH, Rahmati-Yamchi M, Salehi R, Alizadeh E. Novel chemo-photothermal therapy in breast cancer using methotrexate-loaded folic acid conjugated Au@ SiO2 nanoparticles. Nanoscale Res Lett. 2020;15:1\u201314.","journal-title":"Nanoscale Res Lett"},{"issue":"44","key":"4520_CR92","doi-asserted-by":"publisher","first-page":"44846","DOI":"10.1021\/acsomega.4c08797","volume":"9","author":"M Broadbent","year":"2024","unstructured":"Broadbent M, Chadwick SJ, Brust M, Volk M. Gold nanoparticles for photothermal and photodynamic therapy. ACS omega. 2024;9(44):44846\u201359.","journal-title":"ACS omega"},{"issue":"19","key":"4520_CR93","doi-asserted-by":"publisher","first-page":"27816","DOI":"10.1021\/acsami.5c00084","volume":"17","author":"SA Camacho","year":"2025","unstructured":"Camacho SA, Aoki PHB, Ekstrand F, Oliveira ON Jr, Prinz CN. Enhancing photothermal therapy against breast cancer cells by modulating the end point of gold shell-isolated nanoparticles using nanostraw-assisted injection. ACS Appl Mater Interfaces. 2025;17(19):27816\u201328.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4520_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12645-024-00250-w","volume":"15","author":"Y Dutta Gupta","year":"2024","unstructured":"Dutta Gupta Y, Mackeyev Y, Krishnan S, Bhandary S. Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics. Cancer Nanotechnol. 2024;15(1):9.","journal-title":"Cancer Nanotechnol"},{"key":"4520_CR95","unstructured":"Branda F, Costantini A, Luciani G, Silvestri B. Smart nanoparticles for cancer therapy. AICIng 2012 VIII Convegno Nazionale dell\u2019Associazione di Chimica per Ingegneria; 2012."},{"key":"4520_CR96","doi-asserted-by":"publisher","first-page":"122099","DOI":"10.1016\/j.ijpharm.2022.122099","volume":"625","author":"F Ahmadi","year":"2022","unstructured":"Ahmadi F, Sodagar-Taleghani A, Ebrahimnejad P, Moghaddam SPH, Ebrahimnejad F, Asare-Addo K, Nokhodchi A. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer. Int J Pharm. 2022;625:122099.","journal-title":"Int J Pharm"},{"key":"4520_CR97","doi-asserted-by":"publisher","first-page":"115127","DOI":"10.1016\/j.inoche.2025.115127","volume":"181","author":"AY Abbas","year":"2025","unstructured":"Abbas AY, Sulaiman GM, Khan RA, Mohammed HA. Hesperidin-methotrexate dual drugs-loaded mesoporous silica nanoparticles: dose reductions, bioavailability increments, and enhanced anti-cancer activity with organs safety. Inorg Chem Commun. 2025;181:115127.","journal-title":"Inorg Chem Commun"},{"issue":"17","key":"4520_CR98","doi-asserted-by":"publisher","first-page":"9652","DOI":"10.3390\/ijms22179652","volume":"22","author":"V Miku\u0161ov\u00e1","year":"2021","unstructured":"Miku\u0161ov\u00e1 V, Miku\u0161 P. Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci. 2021;22(17):9652.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4520_CR99","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3390\/ijms24054289","volume":"24","author":"OR Guadarrama-Escobar","year":"2023","unstructured":"Guadarrama-Escobar OR, Serrano-Casta\u00f1eda P, Anguiano-Almaz\u00e1n E, V\u00e1zquez-Dur\u00e1n A, Pe\u00f1a-Ju\u00e1rez MC, Vera-Graziano R, Morales-Florido MI, Rodriguez-Perez B, Rodriguez-Cruz IM, Miranda-Calder\u00f3n JE, Escobar-Ch\u00e1vez JJ. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24(5):4289.","journal-title":"Int J Mol Sci"},{"key":"4520_CR100","doi-asserted-by":"publisher","first-page":"124897","DOI":"10.1016\/j.ijpharm.2024.124897","volume":"667","author":"A Karimian-Shaddel","year":"2024","unstructured":"Karimian-Shaddel A, Dadashi H, Mashinchian M, Mohabbat A, Nazemiyeh AR, Vandghanooni S, Eskandani M. Codelivery of metformin and methotrexate with optimized chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo. Int J Pharm. 2024;667:124897. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124897.","journal-title":"Int J Pharm"},{"key":"4520_CR101","doi-asserted-by":"publisher","first-page":"147232","DOI":"10.1016\/j.ijbiomac.2025.147232","volume":"327","author":"S Ahrar","year":"2025","unstructured":"Ahrar S, Bagheri F, Ganji F. Redox-triggered hyaluronic acid polymersomes for co-delivery of methotrexate and curcumin to breast cancer cells. Int J Biol Macromol. 2025;327:147232.","journal-title":"Int J Biol Macromol"},{"key":"4520_CR102","doi-asserted-by":"publisher","first-page":"126293","DOI":"10.1016\/j.ijpharm.2025.126293","volume":"686","author":"A Aliabadi","year":"2025","unstructured":"Aliabadi A, Ramezani M, Sheikhi-Mohammareh S, Abnous K, Taghdisi SM, Alibolandi M. Synthesis of glutathione-responsive, amphiphilic methotrexate-based prodrug nanoparticles: in vitro and in vivo assessment against metastatic breast cancer. Int J Pharm. 2025;686:126293.","journal-title":"Int J Pharm"},{"issue":"11","key":"4520_CR103","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/polym17111453","volume":"17","author":"A Stefanache","year":"2025","unstructured":"Stefanache A, Lungu II, Anton N, Damir D, Gutu C, Olaru I, Plesea Condratovici A, Duceac M, Constantin M, Calin G. Chitosan nanoparticle-based drug delivery systems: advances, challenges, and future perspectives. Polymers. 2025;17(11):1453.","journal-title":"Polymers"},{"key":"4520_CR104","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.ntm.2024.100040","volume":"3","author":"AK Grewal","year":"2024","unstructured":"Grewal AK, Salar RK. Chitosan nanoparticle delivery systems: an effective approach to enhancing efficacy and safety of anticancer drugs. Nano TransMed. 2024;3:100040.","journal-title":"Nano TransMed"},{"issue":"21","key":"4520_CR105","doi-asserted-by":"publisher","first-page":"10735","DOI":"10.3390\/ijms262110735","volume":"26","author":"A Dambuza","year":"2025","unstructured":"Dambuza A, Mokolokolo PP, Makhatha ME, Sibeko MA. Pharmacological and biological efficacy of chitosan-based materials. Int J Mol Sci. 2025;26(21):10735.","journal-title":"Int J Mol Sci"},{"key":"4520_CR106","doi-asserted-by":"publisher","first-page":"107395","DOI":"10.1016\/j.jddst.2025.107395","volume":"113","author":"AA El Abd-Elfadel","year":"2025","unstructured":"Abd-Elfadel AA, Ewees MGE-D, Aboud HM, El Rouby WMA, Farghali AA, Zanaty MI. Evaluating the efficacy of bilosomes as a promising nanovector for methotrexate against breast cancer. J Drug Deliv Sci Technol. 2025;113:107395.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4520_CR107","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.jddst.2024.106539","volume":"104","author":"M Shinde","year":"2025","unstructured":"Shinde M, Jagadale M, Naikwade A, Mali U, Parulekar R, Gophane A, Gaikwad V, Patil S, Bhatia M. Unleashing potential of methotrexate-amino acid methyl ester-loaded lipidic nanocapsules as magic bullets against resistant breast cancer. J Drug Deliv Sci Technol. 2025;104:106539.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"4520_CR108","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/ph16030349","volume":"16","author":"CH Kim","year":"2023","unstructured":"Kim CH, Lee S, Choi JY, Lyu MJ, Jung HM, Goo YT, Kang MJ, Choi YW. Functionalized lipid nanocarriers for simultaneous delivery of docetaxel and tariquidar to chemoresistant cancer cells. Pharmaceuticals. 2023;16(3):349.","journal-title":"Pharmaceuticals"},{"key":"4520_CR109","doi-asserted-by":"publisher","first-page":"103323","DOI":"10.1016\/j.jddst.2022.103323","volume":"71","author":"CH Kim","year":"2022","unstructured":"Kim CH, Lee TH, Kim BD, Kim HK, Lyu MJ, Jung HM, Goo YT, Kang MJ, Lee S, Choi YW. Co-administration of tariquidar using functionalized nanostructured lipid carriers overcomes resistance to docetaxel in multidrug resistant MCF7\/ADR cells. J Drug Deliv Sci Technol. 2022;71:103323.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"15","key":"4520_CR110","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.addr.2008.08.003","volume":"60","author":"DK Chatterjee","year":"2008","unstructured":"Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60(15):1627\u201337.","journal-title":"Adv Drug Deliv Rev"},{"key":"4520_CR111","doi-asserted-by":"publisher","first-page":"120421","DOI":"10.1016\/j.ijpharm.2021.120421","volume":"599","author":"L Khalili","year":"2021","unstructured":"Khalili L, Dehghan G, Feizi MAH, Sheibani N, Hamishekar H. Development of an albumin decorated lipid-polymer hybrid nanoparticle for simultaneous delivery of methotrexate and conferone to cancer cells. Int J Pharm. 2021;599:120421.","journal-title":"Int J Pharm"},{"issue":"6","key":"4520_CR112","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/molecules23061419","volume":"23","author":"DM Shadrack","year":"2018","unstructured":"Shadrack DM, Swai HS, Munissi JJE, Mubofu EB, Nyandoro SS. Polyamidoamine dendrimers for enhanced solubility of small molecules and other desirable properties for site specific delivery: insights from experimental and computational studies. Molecules. 2018;23(6):1419.","journal-title":"Molecules"},{"key":"4520_CR113","doi-asserted-by":"crossref","unstructured":"Torres-P\u00e9rez SA, Ramos-God\u00ednez MD, Ram\u00f3n-Gallegos E. Effect of methotrexate conjugated PAMAM dendrimers on the viability of breast cancer cells. AIP Publishing; 2019.","DOI":"10.1063\/1.5095929"},{"key":"4520_CR114","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s10008-016-3227-2","volume":"20","author":"H Li","year":"2016","unstructured":"Li H, Wang X, Wang Z, Zhao W. Simultaneous determination of guanine, adenine, thymine and cytosine with a simple electrochemical method. J Solid State Electrochem. 2016;20:2223\u201330.","journal-title":"J Solid State Electrochem"},{"issue":"4","key":"4520_CR115","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/adhm.201200338","volume":"2","author":"KH Bae","year":"2013","unstructured":"Bae KH, Lee JY, Lee SH, Park TG, Nam YS. Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging. Adv Healthc Mater. 2013;2(4):576\u201384.","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"4520_CR116","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/md21030177","volume":"21","author":"SL Tomi\u0107","year":"2023","unstructured":"Tomi\u0107 SL, Babi\u0107 Radi\u0107 MM, Vukovi\u0107 JS, Filipovi\u0107 VV, Nikodinovic-Runic J, Vukomanovi\u0107 M. Alginate-based hydrogels and scaffolds for biomedical applications. Mar Drugs. 2023;21(3):177.","journal-title":"Mar Drugs"},{"key":"4520_CR117","doi-asserted-by":"publisher","first-page":"213948","DOI":"10.1016\/j.bioadv.2024.213948","volume":"163","author":"R Singh","year":"2024","unstructured":"Singh R, Yadav D, Ingole PG, Ahn Y-H. Magnetic engineering nanoparticles: versatile tools revolutionizing biomedical applications. Biomater. Adv. 2024;163:213948.","journal-title":"Biomaterials Adv"},{"issue":"9","key":"4520_CR118","doi-asserted-by":"publisher","first-page":"1901058","DOI":"10.1002\/adhm.201901058","volume":"9","author":"A Farzin","year":"2020","unstructured":"Farzin A, Etesami SA, Quint J, Memic A, Tamayol A. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthc Mater. 2020;9(9):1901058.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"4520_CR119","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/jbm.b.33302","volume":"103","author":"EEL Lewis","year":"2015","unstructured":"Lewis EEL, Child HW, Hursthouse A, Stirling D, McCully M, Paterson D, Mullin M, Berry CC. The influence of particle size and static magnetic fields on the uptake of magnetic nanoparticles into three dimensional cell-seeded collagen gel cultures. J Biomed Mater Res Part B Appl Biomater. 2015;103(6):1294\u2013301.","journal-title":"J Biomedical Mater Res Part B: Appl Biomaterials"},{"key":"4520_CR120","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.mtbio.2024.101377","volume":"30","author":"JLY Tang","year":"2025","unstructured":"Tang JLY, Moonshi SS, Wu Y, Cowin G, Vazquez-Prada KX, Tran HDN, Bulmer AC, Ta HT. A methotrexate labelled dual metal oxide nanocomposite for long-lasting anti-cancer theranostics. Mater Today Bio. 2025;30:101377.","journal-title":"Mater Today Bio"},{"issue":"2","key":"4520_CR121","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1166\/jbn.2016.2175","volume":"12","author":"EG Graham","year":"2016","unstructured":"Graham EG, Wailes EM, Levi-Polyachenko NH. Multi-walled carbon nanotubes inhibit breast cancer cell migration. J Biomed Nanotechnol. 2016;12(2):308\u201319.","journal-title":"J Biomed Nanotechnol"},{"issue":"36","key":"4520_CR122","doi-asserted-by":"publisher","first-page":"12945","DOI":"10.1523\/JNEUROSCI.1332-11.2011","volume":"31","author":"G Cellot","year":"2011","unstructured":"Cellot G, Toma FM, Varley ZK, Laishram J, Villari A, Quintana M, Cipollone S, Prato M, Ballerini L. Carbon nanotube scaffolds tune synaptic strength in cultured neural circuits: novel frontiers in nanomaterial\u2013tissue interactions. J Neurosci. 2011;31(36):12945\u201353.","journal-title":"J Neurosci"},{"issue":"10","key":"4520_CR123","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4155\/tde-2020-0019","volume":"11","author":"BF Dizaji","year":"2020","unstructured":"Dizaji BF, Farboudi A, Rahbar A, Azarbaijan MH, Asgary MR. The role of single-and multi-walled carbon nanotube in breast cancer treatment. Ther Deliv. 2020;11(10):653\u201372.","journal-title":"Therapeutic Delivery"},{"issue":"3","key":"4520_CR124","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/nano13030556","volume":"13","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Maniyar A, Sarkar M, Sarkar TR, Neelgund GM. The cytotoxicity of carbon nanotubes and hydroxyapatite, and graphene and hydroxyapatite nanocomposites against breast cancer cells. Nanomaterials. 2023;13(3):556.","journal-title":"Nanomaterials"},{"key":"4520_CR125","doi-asserted-by":"publisher","first-page":"1229637","DOI":"10.3389\/fmats.2023.1229637","volume":"10","author":"M Al-zharani","year":"2023","unstructured":"Al-zharani M, Alyami NM, Qurtam AA, Aljarba NH, Alkahtani S, Mubarak M, Daoush WM. Use of multi-walled carbon nanotubes (MWCNTs) stabilized in Arabic gum colloidal solution to induce genotoxicity and apoptosis of human breast and lung cancer cell lines. Front Mater. 2023;10:1229637.","journal-title":"Front Mater"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04520-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04520-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04520-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:03:05Z","timestamp":1775142185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04520-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4520"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04520-x","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}